JPH0361436B2 - - Google Patents

Info

Publication number
JPH0361436B2
JPH0361436B2 JP20726683A JP20726683A JPH0361436B2 JP H0361436 B2 JPH0361436 B2 JP H0361436B2 JP 20726683 A JP20726683 A JP 20726683A JP 20726683 A JP20726683 A JP 20726683A JP H0361436 B2 JPH0361436 B2 JP H0361436B2
Authority
JP
Japan
Prior art keywords
protocatechuic acid
acid
medium
carbon source
corynebacterium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP20726683A
Other languages
Japanese (ja)
Other versions
JPS6098989A (en
Inventor
Katsuaki Sato
Nobuyuki Sugimoto
Takashi Tanaka
Hitoshi Ei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP20726683A priority Critical patent/JPS6098989A/en
Publication of JPS6098989A publication Critical patent/JPS6098989A/en
Publication of JPH0361436B2 publication Critical patent/JPH0361436B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は発酵法によるプロトカテク酸の製造法
に関する。プロトカテク酸は食品用抗酸化剤の原
料として、又香料としての用途を有するバニリン
の原料、更には各種医薬品の原料として有用であ
る。従来プロトカテの酸を培地中に蓄積する菌と
してノイロスポラ属菌の変異株(バイオケミカル
ジヤーナル68、168、1958年)、コリネバクテリウ
ム属菌の変異株(特公昭45−39036)、ブレビバク
テリウム属菌の変異株(特開昭50−8952)等が報
告されている。 本発明者等は更に効率良くプロトカテク酸を発
酵生産する方法を開発することを目的として研究
を重ねた結果、ブレビバクテリウム属又はコリネ
バクテリウム属に属し、唯一の炭素源としてプロ
トカテク酸では生育できない変異株の中に多量の
プロトカテク酸を生成、蓄積する菌株が存在する
ことを見い出した。 本発明はこの知見に基づいて完成されたもので
ある。 本発明において、プロトカテク酸生産能を有す
る微生物はブレビバクテリウム属又はコリネバク
テリウム属等のコリネ型細菌に属し、プロトカテ
ク酸生産に必要な性質、例えばパラフルオロフエ
ニルアラニン、メタフルオロフエニルアラニン、
チロシンハイドロキサメート又は5−メチルトリ
プトフアン等の芳香族アミノ酸アナログ耐性もし
くはチロシン、フエニルアラニン、トリプトフア
ン等の芳香族アミノ酸の単独ないし、複合要求
性、更には芳香族アミノ酸生合成系の中間体であ
るシキミ酸やコリスミン酸等の要求性を有する微
生物である。 本発明において使用される変異株はブレビバク
テリウム属又はコリネバクテリウム属等のコリネ
型細菌に属し上記プロトカテク酸生産能を有する
性質を示し、かつ唯一の炭素源としてプロトカテ
ク酸で生育できない性質を有する変異株である。 本発明において用いられる微生物は、具体的に
は例えば ブレビバクテリウム・ ブレビバクテリウム・ ラクトフエルメンタム AJ 12106 FERM P−73
33 (mFPr、PCA分解活性欠失) ブレビバクテリウム・ ブレビバクテリウム・ ラクトフエルメンタム AJ 12107 FERM P−73
34 (PFPr、Try-、PCA分解活性欠失) コリネバクテリウム・ コリネバクテリウム・ アセトアシドフイラム AJ 12108 FERM P−73
35 (PFPr、PCA分解活性欠失) mFPr:メタフルオロフエニルアラニン
耐性 PCA分解活性欠失:プロトカテク酸分
解能欠失 Try-:L−チロシン要求性 pFPr:パラフルオロフエニルアラニン
耐性 これら本発明の変異株は、ブレビバクテリウム
属又はコリネバクテリウム属の微生物を親株とし
て、これに通常の変異誘導操作例えば紫外線、X
線照射あるいはN−メチル−N′−ニトロ−N−
ニトロソグアニジン(NTGと略す)、亜硝酸等の
化学薬剤処理を施し、変異処理した菌体を完全培
地を含む寒天平板上で培養し、唯一の炭素源とし
て各々グルコース又はプロトカテク酸を含む最少
寒天平板培地上にレプリカする。このようにして
唯一の炭素源としてグルコースでは生育できる
が、プロトカテク酸では生育できないコロニーを
分離することによつて得られる。又最少培地に含
む唯一の炭素源としてはプロトカテク酸の他に、
キナ酸又はシキミ酸であつても何らさしつかえな
い。 次に本発明で使用する変異株の変異誘導法を以
下の実験例にて示す。 実験例 1 ブレビバクテリウム・ラクトフエルメンタム
AJ12105(FERMP−7332)をイーストブイヨン
寒天斜面培地で培養し、生育した菌体を集めて1/
50Mリン酸緩衝液(PH7.0)に懸濁し(108〜109
コ/mlの菌体を含む)、これにNTGを加え
(NTG濃度は1000μg/ml)、室温で30分間保持
した。このようにしてNTG処理した菌体を同リ
ン酸緩衝液で充分洗浄した後、完全寒天平板培地
上にコロニー数が200コ程度になるように菌液を
適当に希釈して塗布し、3〜4日間31.5℃で培養
した。 次に第1表に示す唯一の炭素源としてグルコー
ス又はプロトカテク酸を各々に含む最少寒天平板
培地上にレプリカし、プロトカテク酸培地で生育
せず、グルコースを唯一の炭素源とする最少寒天
培地上で生育するコロニーを分離した。このよう
にして得られた変異株の中にはすぐれたプロトカ
テク酸生産性を示す菌株が数多く存在した。 この内生産能の最も高い菌株AJ12106を選ん
だ。同様の変異操作によりブレビバクテリウム・
ラクトフエルメンタムAJ3436(FERM−P1913)
を親株としてAJ12107を選んだ。 第1表 最少培地の組成成 分 含 量 グルコース 10g/ 又はプロトカテク酸 5 〃 硫酸アンモニウム 5 〃 尿 素 2 〃 KH2PO4 1 〃 MgSO4・7H2O 1 〃 Fe++、Mn++イオン 各2ppm Biotin 50μg/ VB1・HCl 2000 〃 DL−メチオニン 400mg/g L−Tyr 100 〃 PH7.0(KOH) 又同様の変異操作によりコリネバクテリウム・
アセトアシドフイラムATCC13870を親株として
同様な方法でAJ12108を誘導した。 次にこのようにして得た変異株についてグルコ
ース又はプルトカテク酸を唯一の炭素源とする最
少培地での生育の結果を第2表に示す。
The present invention relates to a method for producing protocatechuic acid by fermentation. Protocatechuic acid is useful as a raw material for food antioxidants, as a raw material for vanillin, which has uses as a flavoring agent, and as a raw material for various pharmaceutical products. Conventional bacteria that accumulate protocate acid in the culture medium include a mutant strain of the genus Neurospora (Biochemical Journal 68, 168, 1958), a mutant strain of the genus Corynebacterium (Japanese Patent Publication No. 45-39036), and a mutant strain of the genus Brevibacterium. Mutant strains of the bacterium (Japanese Unexamined Patent Publication No. 1989-8952) have been reported. As a result of repeated research aimed at developing a more efficient fermentation production method for protocatechuic acid, the present inventors found that the genus Brevibacterium or Corynebacterium cannot grow on protocatechuic acid as the sole carbon source. We found that among the mutant strains, there are strains that produce and accumulate large amounts of protocatechuic acid. The present invention was completed based on this knowledge. In the present invention, the microorganism capable of producing protocatechuic acid belongs to coryneform bacteria such as the genus Brevibacterium or the genus Corynebacterium, and has properties necessary for producing protocatechuic acid, such as parafluorophenylalanine, metafluorophenylalanine,
Resistance to aromatic amino acid analogs such as tyrosine hydroxamate or 5-methyltryptophan, individual or combined requirements for aromatic amino acids such as tyrosine, phenylalanine, and tryptophan, and intermediates in the aromatic amino acid biosynthesis system It is a microorganism that requires shikimic acid and chorismic acid. The mutant strain used in the present invention belongs to coryneform bacteria such as the genus Brevibacterium or Corynebacterium and exhibits the above-mentioned ability to produce protocatechuic acid, and also has the property of not being able to grow on protocatechuic acid as the sole carbon source. It is a mutant strain. The microorganism used in the present invention is specifically, for example, Brevibacterium Brevibacterium lactofermentum AJ 12106 FERM P-73
33 (mFP r , PCA degrading activity deleted) Brevibacterium Brevibacterium lactofermentum AJ 12107 FERM P-73
34 (PFP r , Try - , PCA degrading activity deleted) Corynebacterium Corynebacterium acetoacidophyllum AJ 12108 FERM P-73
35 (PFP r , PCA decomposition activity deficiency) mFP r : Metafluorophenylalanine resistance PCA decomposition activity deficiency : Protocatechuic acid decomposition ability deficiency Try - : L-tyrosine requirement pFP r : Parafluorophenylalanine resistance These books The mutant strain of the invention is produced by using a microorganism of the genus Brevibacterium or Corynebacterium as a parent strain, and subjecting it to conventional mutagenesis operations such as ultraviolet rays, X-rays, etc.
irradiation or N-methyl-N'-nitro-N-
The mutagenized bacterial cells were treated with chemical agents such as nitrosoguanidine (abbreviated as NTG) and nitrous acid, and cultured on agar plates containing complete medium, and minimal agar plates containing glucose or protocatechuic acid, respectively, as the sole carbon source. Replica onto the medium. In this way, it is obtained by isolating colonies that can grow on glucose as the sole carbon source, but not on protocatechuic acid. In addition to protocatechuic acid, the only carbon source contained in the minimal medium is
There is no problem even if it is quinic acid or shikimic acid. Next, a method for inducing mutations in mutant strains used in the present invention will be shown in the following experimental examples. Experimental example 1 Brevibacterium lactofermentum
AJ12105 (FERMP-7332) was cultured on yeast broth agar slant medium, and the grown cells were collected and 1/
Suspend in 50M phosphate buffer (PH7.0) (10 8 - 10 9
NTG was added to this (NTG concentration was 1000 μg/ml), and the mixture was kept at room temperature for 30 minutes. After thoroughly washing the NTG-treated bacterial cells with the same phosphate buffer, the bacterial solution was appropriately diluted and applied on a complete agar plate so that the number of colonies was approximately 200, and the bacterial solution was spread on a complete agar plate for 3 to 30 minutes. The cells were cultured at 31.5°C for 4 days. Next, it is replicated on a minimal agar plate medium each containing glucose or protocatechuic acid as the sole carbon source as shown in Table 1, and grown on a minimal agar medium containing glucose as the sole carbon source without growing on the protocatechuic acid medium. Growing colonies were isolated. Among the mutant strains thus obtained, there were many strains exhibiting excellent protocatechuic acid productivity. Among these, strain AJ12106 with the highest production capacity was selected. Brevibacterium bacterium
Lactofermentum AJ3436 (FERM−P1913)
AJ12107 was selected as the parent stock. Table 1 Composition of minimal medium Glucose 10g/or protocatechuic acid 5 Ammonium sulfate 5 Urea 2 KH 2 PO 4 1 MgSO 4・7H 2 O 1 Fe ++ , Mn ++ ions 2 ppm each Biotin 50μg/ VB 1・HCl 2000 〃 DL-Methionine 400mg/g L-Tyr 100 〃 PH7.0 (KOH) Corynebacterium spp.
AJ12108 was induced in the same manner using acetoacidophyllum ATCC13870 as the parent strain. Next, Table 2 shows the results of growth of the mutant strains thus obtained in a minimal medium containing glucose or plutocatechuic acid as the sole carbon source.

【表】 実験方法は、各変異株の菌体を第1表の最少培
地で良く洗浄した後、小型試験官に入れた第2表
に示す所定量の炭素源を含む最少培地(4ml)に
一定量接種し、31.5℃で24時間振盪培養を行い、
培養液の560nmに於ける吸光度を測定して生育
度を求めた。第2表にはその相対生育値を示し
た。 本発明で使用する培地は炭素源、窒素源、無機
塩類、その他必要に応じてアミノ酸、ビタミン、
核酸等の有機微量栄養素を含有する通常の栄養培
地が使用される。炭素源としては使用する変異株
の利用可能なものであれば良く、例えばグルコー
ス、フラクトース、シユークロース、マルトー
ス、澱粉分解物糖蜜糖の糖類が使用され、その
他、エタノール、プロパノール等のアルコール
類、酢酸、クエン酸等の有機酸類、更に菌株によ
つてはノルマルパラフイン等も単独あるいは他の
炭素源と併用して使用される。 窒素源としては硫酸アンモニウム、塩化アンモ
ニウム、リン酸アンモニウム等のアンモニウム
塩、硝酸塩、尿素、アンモニア、肉エキス等無機
あるいは有機の窒素源が使用される。有機微量栄
養素としてはアミノ酸、ビタミン、脂肪酸、核
酸、更にこれらのものを含有するペプトン、カザ
ミノ酸、酵母エキス、蛋白分解物等が使用され、
生育にアミノ酸等を要求する栄養要求性変異株を
使用する場合には要求される栄養素を補添するこ
とが必要である。 培養は好気的条件で行うことが望ましく、培養
期間中培地のPHを5ないし9、温度を20℃ないし
40℃に制御しつつ1日ないし4日間振盪培養又は
通気撹拌培養することによりプロトカテク酸が多
量培養液中に蓄積される。培養液からプロトカテ
ク酸を採取する方法は公知の方法で従つて行えば
良く、培養液から菌体を分離除去した後、イオン
交換樹脂を用いる方法等により採取される。 以下、実施例にて説明する。 実施例 1 下記第3表に示すプロトカテク酸生産用培地を
調製し、500ml容振盪フラスコに20ml宛分注し、
120℃で10分間加熱滅菌した。これに別途加熱殺
菌した炭酸カルシウム粉末1.0gを補添した。
[Table] The experimental method was to thoroughly wash the bacterial cells of each mutant strain with the minimal medium shown in Table 1, and then place them in a minimal medium (4 ml) containing the specified amount of carbon source shown in Table 2, which was placed in a small tester. Inoculate a certain amount and culture with shaking at 31.5℃ for 24 hours.
The degree of growth was determined by measuring the absorbance of the culture solution at 560 nm. Table 2 shows the relative growth values. The medium used in the present invention contains carbon sources, nitrogen sources, inorganic salts, amino acids, vitamins, etc. as necessary.
Conventional nutrient media containing organic micronutrients such as nucleic acids are used. The carbon source may be any carbon source that can be used by the mutant strain used; for example, glucose, fructose, sucrose, maltose, saccharides such as starch decomposition product molasses can be used, and other carbon sources include alcohols such as ethanol and propanol, acetic acid, Organic acids such as citric acid, and depending on the strain, normal paraffin and the like are also used alone or in combination with other carbon sources. As the nitrogen source, inorganic or organic nitrogen sources such as ammonium salts such as ammonium sulfate, ammonium chloride, and ammonium phosphate, nitrates, urea, ammonia, and meat extracts are used. As organic micronutrients, amino acids, vitamins, fatty acids, nucleic acids, peptones containing these things, casamino acids, yeast extracts, protein decomposition products, etc. are used.
When using an auxotrophic mutant strain that requires amino acids and the like for growth, it is necessary to supplement the required nutrients. It is desirable to culture under aerobic conditions, with the pH of the medium being between 5 and 9 and the temperature between 20°C and 20°C.
A large amount of protocatechuic acid is accumulated in the culture solution by culturing with shaking or stirring with aeration for 1 to 4 days while controlling the temperature at 40°C. Protocatechuic acid may be collected from the culture solution by any known method, and after separating and removing the bacterial cells from the culture solution, protocatechuic acid is collected by a method using an ion exchange resin or the like. Examples will be described below. Example 1 A protocatechuic acid production medium shown in Table 3 below was prepared and dispensed to 20 ml into a 500 ml shaking flask.
Heat sterilization was performed at 120°C for 10 minutes. To this was added 1.0 g of calcium carbonate powder which had been separately heat sterilized.

【表】 この培地に第4表に示すプロトカテク酸生産菌
を1白金耳接種し、30℃で72時間振盪培養した。
培養液中のプロトカテク酸生成量を測定し、その
結果を第4表に示した。
[Table] One platinum loop of the protocatechuic acid-producing bacteria shown in Table 4 was inoculated into this medium, and cultured with shaking at 30°C for 72 hours.
The amount of protocatechuic acid produced in the culture solution was measured, and the results are shown in Table 4.

【表】【table】

【表】【table】

Claims (1)

【特許請求の範囲】[Claims] 1 ブレビバクテリウム属又はコリネバクテリウ
ム属に属し、唯一の炭素源としてプロトカテク酸
では生育できずかつプロトカテク酸生産能を有す
る変異株を培養してプロトカテク酸を培地中に生
成、蓄積せしめこれを採取することを特徴とする
発酵法によるプロトカテク酸の製造法。
1 Cultivating a mutant strain belonging to the genus Brevibacterium or Corynebacterium that cannot grow on protocatechuic acid as a sole carbon source and has the ability to produce protocatechuic acid, produces and accumulates protocatechuic acid in the medium, and collects it. A method for producing protocatechuic acid by a fermentation method, characterized by:
JP20726683A 1983-11-04 1983-11-04 Production of protocatechuic acid by fermentation Granted JPS6098989A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP20726683A JPS6098989A (en) 1983-11-04 1983-11-04 Production of protocatechuic acid by fermentation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20726683A JPS6098989A (en) 1983-11-04 1983-11-04 Production of protocatechuic acid by fermentation

Publications (2)

Publication Number Publication Date
JPS6098989A JPS6098989A (en) 1985-06-01
JPH0361436B2 true JPH0361436B2 (en) 1991-09-19

Family

ID=16536942

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20726683A Granted JPS6098989A (en) 1983-11-04 1983-11-04 Production of protocatechuic acid by fermentation

Country Status (1)

Country Link
JP (1) JPS6098989A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104379729B (en) 2012-07-03 2020-07-21 花王株式会社 Process for producing useful microorganism and target substance

Also Published As

Publication number Publication date
JPS6098989A (en) 1985-06-01

Similar Documents

Publication Publication Date Title
JPH03232497A (en) Production of l-glutamine by fermentation
JP2810697B2 (en) Method for producing aromatic amino acids
JPH0362394B2 (en)
JPS6257315B2 (en)
JP2876739B2 (en) Production method of L-lysine by fermentation method
JPH0362395B2 (en)
JP2817185B2 (en) Method for producing L-ornithine by fermentation
JP3006929B2 (en) Production method of L-valine by fermentation method
JP2578463B2 (en) Production method of L-lysine by fermentation method
JPH0361436B2 (en)
JPS6155958B2 (en)
JPH0644871B2 (en) Fermentation method for producing L-leucine
JPH0665314B2 (en) Fermentation method for producing L-valine
US5362636A (en) Process for producing L-lysine by fermentation with a bacteria having selenalysine resistance
JPH02234686A (en) Production of l-lysine by fermentation method
JPH0456598B2 (en)
JPH0211238B2 (en)
HU215248B (en) Process for producing l-lysine
JPH0211236B2 (en)
JPH0594A (en) Production of anthranilic acid by fermentation
JPH0347840B2 (en)
JPH0429354B2 (en)
JPH0314436B2 (en)
JP2578496B2 (en) Production method of inosine by fermentation method
JPH055476B2 (en)